San Diego, CA, October 27, 2013 --(PR.com
)-- Francisco Leon, Vice President and Head of Immunology Translational Medicine at Janssen R&D, will give a plenary keynote presentation on “Translational Strategies in the Development of Novel Immunotherapeutics” at the 6th Immunotherapeutics & Immunomonitoring Conference to be held in San Diego, CA on January 29-31, 2014 by GTC.
Francisco Leon, MD PhD, is a clinical immunologist who received his MD from Autónoma University in Madrid, Spain. In the Biotech and Pharmaceutical Industry, Francisco Leon has focused on early-stage development and translational research in immunologic diseases (rheumatoid arthritis, transplantation, IBD, psoriasis, celiac disease, asthma, etc) in Bristol-Myers Squibb, MedImmune, Alba Therapeutics and Centocor/Janssen. Francisco is also Adjunct Research Associate Professor of Medicine at Jefferson Medical College (Philadelphia). He has authored or co-authored over 60 peer-reviewed articles and book chapters as well as several patents.
Network with leading experts from the scientific and clinical arenas as well as investigators in industry to discuss novel findings and developments in immunological assays and procedures. Learn about recent advances in immunotherapy, as they relate to various modalities, specific cancers, cell subsets, and animal models. Discuss Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.
The 6th Immunotherapeutics & Immunomonitoring Conference is part of the Novel Immunotherapeutics Summit 2014, which includes three additional parallel conferences:
12th Cytokines & Inflammation
2nd Immunogenicity & Immunotoxicity
Inaugural Innate Immunity
For more information, please visit www.gtcbio.com